Sung Lee - Net Worth and Insider Trading

Sung Lee Net Worth

The estimated net worth of Sung Lee is at least $950,654 dollars as of 2024-11-05. Sung Lee is the EVP & CFO of Vir Biotechnology Inc and owns about 100,492 shares of Vir Biotechnology Inc (VIR) stock worth over $950,654. Details can be seen in Sung Lee's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sung Lee has not made any transactions after 2024-03-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Sung Lee

To

Sung Lee Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sung Lee owns 2 companies in total, including Sangamo Therapeutics Inc (SGMO) , and Vir Biotechnology Inc (VIR) .

Click here to see the complete history of Sung Lee’s form 4 insider trades.

Insider Ownership Summary of Sung Lee

Ticker Comapny Transaction Date Type of Owner
SGMO Sangamo Therapeutics Inc 2019-10-31 EVP & Chief Financial Officer
VIR Vir Biotechnology Inc 2024-03-27 Chief Financial Officer

Sung Lee Latest Holdings Summary

Sung Lee currently owns a total of 1 stock. Sung Lee owns 100,492 shares of Vir Biotechnology Inc (VIR) as of March 27, 2024, with a value of $950,654.

Latest Holdings of Sung Lee

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VIR Vir Biotechnology Inc 2024-03-27 100,492 9.46 950,654

Holding Weightings of Sung Lee


Sung Lee Form 4 Trading Tracker

According to the SEC Form 4 filings, Sung Lee has made a total of 1 transactions in Vir Biotechnology Inc (VIR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Vir Biotechnology Inc is the sale of 6,008 shares on March 27, 2024, which brought Sung Lee around $59,419.

Insider Trading History of Sung Lee

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sung Lee Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sung Lee Ownership Network

Ownership Network List of Sung Lee

No Data

Ownership Network Relation of Sung Lee

Insider Network Chart

Sung Lee Owned Company Details

What does Sangamo Therapeutics Inc do?

Who are the key executives at Sangamo Therapeutics Inc?

Sung Lee is the EVP & Chief Financial Officer of Sangamo Therapeutics Inc. Other key executives at Sangamo Therapeutics Inc include 10 percent owner Biogen Inc. , SVP-Chief Development Officer Nathalie Dubois-stringfellow , and 10 percent owner Biogen Ma Inc. .

Sangamo Therapeutics Inc (SGMO) Insider Trades Summary

Over the past 18 months, Sung Lee made no insider transaction in Sangamo Therapeutics Inc (SGMO). Other recent insider transactions involving Sangamo Therapeutics Inc (SGMO) include a net sale of 6,000,000 shares made by Biogen Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of Sangamo Therapeutics Inc (SGMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,000,000 shares of Sangamo Therapeutics Inc (SGMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,000,000 shares.

Sangamo Therapeutics Inc (SGMO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sangamo Therapeutics Inc Insider Transactions

No Available Data

Sung Lee Mailing Address

Above is the net worth, insider trading, and ownership report for Sung Lee. You might contact Sung Lee via mailing address: 7000 Marina Blvd, Brisbane Ca 94005.